QuiO raises $1m for smart injection device

QuiO said last week that it closed a $1.05 million seed round led by undisclosed investors to finish developing its smart injection device, prep for pilot studies and a 510(k) submission.

The New York-based company is developing smart injection devices and software to monitor patient adherence to clinical trial and daily regimens. Average adherence rates for patients using injectable therapies can be as low as 50%, QuiO reported, which results in $14 billion of avoidable medical costs and $22 billion in lost pharmaceutical revenue.

Get the full story at our sister site, Drug Delivery Business News. 

 

The post QuiO raises $1m for smart injection device appeared first on MassDevice.

from MassDevice http://ift.tt/2dHEsnW